In silico modelling demonstrates that user variability during tumour measurement can affect in vivo therapeutic efficacy outcomes
Jake Murkin, Hope E. Amos, Daniel Brough, Karl Turley
The paper shows that user variability in tumor measurement affects the detection of therapeutic efficacy in preclinical studies, with automated methods reducing false negatives.
bioRxiv · Apr 20, 2022 · PreprintBioinformatics